Literature DB >> 27365148

How does adenosine control neuronal dysfunction and neurodegeneration?

Rodrigo A Cunha1,2.   

Abstract

The adenosine modulation system mostly operates through inhibitory A1 (A1 R) and facilitatory A2A receptors (A2A R) in the brain. The activity-dependent release of adenosine acts as a brake of excitatory transmission through A1 R, which are enriched in glutamatergic terminals. Adenosine sharpens salience of information encoding in neuronal circuits: high-frequency stimulation triggers ATP release in the 'activated' synapse, which is locally converted by ecto-nucleotidases into adenosine to selectively activate A2A R; A2A R switch off A1 R and CB1 receptors, bolster glutamate release and NMDA receptors to assist increasing synaptic plasticity in the 'activated' synapse; the parallel engagement of the astrocytic syncytium releases adenosine further inhibiting neighboring synapses, thus sharpening the encoded plastic change. Brain insults trigger a large outflow of adenosine and ATP, as a danger signal. A1 R are a hurdle for damage initiation, but they desensitize upon prolonged activation. However, if the insult is near-threshold and/or of short-duration, A1 R trigger preconditioning, which may limit the spread of damage. Brain insults also up-regulate A2A R, probably to bolster adaptive changes, but this heightens brain damage since A2A R blockade affords neuroprotection in models of epilepsy, depression, Alzheimer's, or Parkinson's disease. This initially involves a control of synaptotoxicity by neuronal A2A R, whereas astrocytic and microglia A2A R might control the spread of damage. The A2A R signaling mechanisms are largely unknown since A2A R are pleiotropic, coupling to different G proteins and non-canonical pathways to control the viability of glutamatergic synapses, neuroinflammation, mitochondria function, and cytoskeleton dynamics. Thus, simultaneously bolstering A1 R preconditioning and preventing excessive A2A R function might afford maximal neuroprotection. The main physiological role of the adenosine modulation system is to sharp the salience of information encoding through a combined action of adenosine A2A receptors (A2A R) in the synapse undergoing an alteration of synaptic efficiency with an increased inhibitory action of A1 R in all surrounding synapses. Brain insults trigger an up-regulation of A2A R in an attempt to bolster adaptive plasticity together with adenosine release and A1 R desensitization; this favors synaptotocity (increased A2A R) and decreases the hurdle to undergo degeneration (decreased A1 R). Maximal neuroprotection is expected to result from a combined A2A R blockade and increased A1 R activation. This article is part of a mini review series: "Synaptic Function and Dysfunction in Brain Diseases".
© 2016 International Society for Neurochemistry.

Entities:  

Keywords:  A1 receptor; A2A receptor; astrocyte; microglia; synaptic plasticity; synaptotoxicity

Mesh:

Substances:

Year:  2016        PMID: 27365148     DOI: 10.1111/jnc.13724

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  122 in total

1.  Enhanced ATP release and CD73-mediated adenosine formation sustain adenosine A2A receptor over-activation in a rat model of Parkinson's disease.

Authors:  Marta Carmo; Francisco Q Gonçalves; Paula M Canas; Jean-Pierre Oses; Francisco D Fernandes; Filipe V Duarte; Carlos M Palmeira; Angelo R Tomé; Paula Agostinho; Geanne M Andrade; Rodrigo A Cunha
Journal:  Br J Pharmacol       Date:  2019-08-01       Impact factor: 8.739

Review 2.  The Role of Adenosine Tone and Adenosine Receptors in Huntington's Disease.

Authors:  David Blum; Yijuang Chern; Maria Rosaria Domenici; Luc Buée; Chien-Yu Lin; William Rea; Sergi Ferré; Patrizia Popoli
Journal:  J Caffeine Adenosine Res       Date:  2018-06-01

Review 3.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

Review 4.  Purinergic system in psychiatric diseases.

Authors:  A Cheffer; A R G Castillo; J Corrêa-Velloso; M C B Gonçalves; Y Naaldijk; I C Nascimento; G Burnstock; H Ulrich
Journal:  Mol Psychiatry       Date:  2017-09-26       Impact factor: 15.992

Review 5.  Impact of Coffee and Cacao Purine Metabolites on Neuroplasticity and Neurodegenerative Disease.

Authors:  Simonetta Camandola; Natalie Plick; Mark P Mattson
Journal:  Neurochem Res       Date:  2018-02-08       Impact factor: 3.996

Review 6.  Mental Fatigue Impairs Endurance Performance: A Physiological Explanation.

Authors:  Kristy Martin; Romain Meeusen; Kevin G Thompson; Richard Keegan; Ben Rattray
Journal:  Sports Med       Date:  2018-09       Impact factor: 11.136

7.  Caffeine Consumption plus Physical Exercise Improves Behavioral Impairments and Stimulates Neuroplasticity in Spontaneously Hypertensive Rats (SHR): an Animal Model of Attention Deficit Hyperactivity Disorder.

Authors:  Angela Patricia França; Marissa Giovanna Schamne; Bruna Soares de Souza; Débora da Luz Scheffer; Angelica Karina Bernardelli; Thiago Corrêa; Geison de Souza Izídio; Alexandra Latini; José Eduardo da Silva-Santos; Paula M Canas; Rodrigo A Cunha; Rui Daniel Prediger
Journal:  Mol Neurobiol       Date:  2020-07-03       Impact factor: 5.590

8.  Adenosine production by brain cells.

Authors:  Edwin K Jackson; Shawn E Kotermanski; Elizabeth V Menshikova; Raghvendra K Dubey; Travis C Jackson; Patrick M Kochanek
Journal:  J Neurochem       Date:  2017-04-06       Impact factor: 5.372

9.  Caffeine has a dual influence on NMDA receptor-mediated glutamatergic transmission at the hippocampus.

Authors:  Robertta S Martins; Diogo M Rombo; Joana Gonçalves-Ribeiro; Carlos Meneses; Vladimir P P Borges-Martins; Joaquim A Ribeiro; Sandra H Vaz; Regina C C Kubrusly; Ana M Sebastião
Journal:  Purinergic Signal       Date:  2020-10-06       Impact factor: 3.765

10.  Neuronal adenosine A2A receptor overexpression is neuroprotective towards 3-nitropropionic acid-induced striatal toxicity: a rat model of Huntington's disease.

Authors:  Maria Rosaria Domenici; Valentina Chiodi; Mirko Averna; Monica Armida; Antonella Pèzzola; Rita Pepponi; Antonella Ferrante; Michael Bader; Kjell Fuxe; Patrizia Popoli
Journal:  Purinergic Signal       Date:  2018-05-16       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.